系统评价:超声通过肠道超声治疗炎症性肠病

IF 6.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Sara Massironi, Alessandra Zilli, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Vipul Jairath, Silvio Danese
{"title":"系统评价:超声通过肠道超声治疗炎症性肠病","authors":"Sara Massironi, Alessandra Zilli, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Vipul Jairath, Silvio Danese","doi":"10.1111/apt.70385","DOIUrl":null,"url":null,"abstract":"BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO<jats:sub>2</jats:sub>‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO<jats:sub>2</jats:sub>e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO<jats:sub>2</jats:sub>e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO<jats:sub>2</jats:sub>e per scan in most studies, and up to 200–300 kg CO<jats:sub>2</jats:sub>e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO<jats:sub>2</jats:sub>e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"53 1","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound\",\"authors\":\"Sara Massironi, Alessandra Zilli, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Vipul Jairath, Silvio Danese\",\"doi\":\"10.1111/apt.70385\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO<jats:sub>2</jats:sub>‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO<jats:sub>2</jats:sub>e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO<jats:sub>2</jats:sub>e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO<jats:sub>2</jats:sub>e per scan in most studies, and up to 200–300 kg CO<jats:sub>2</jats:sub>e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO<jats:sub>2</jats:sub>e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":\"53 1\",\"pages\":\"\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/apt.70385\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.70385","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:炎症性肠病(IBD)是一种慢性、资源密集型疾病,需要反复诊断评估。医疗保健占全球温室气体排放的约5%,而ibd的关键诊断工具——胃肠道(GI)内窥镜检查、计算机断层扫描(CT)和磁共振成像(MRI)——与重大的环境影响有关。然而,这些诊断途径的环境负担仍未得到充分重视。目的系统评估IBD常用的诊断成像方式的碳足迹和环境影响,特别关注肠道超声(IUS)作为一种可持续的低碳替代方法。方法根据PRISMA 2020指南进行系统评价。检索PubMed、Scopus和Embase,从成立到2025年5月,检索与IBD护理相关的诊断模式(胃肠道内窥镜、CT、MRI和IUS)对环境影响的研究。包括提供碳足迹、能源消耗、废物产生或可持续性指标的定量或定性数据的研究。数据以叙述的方式合成。结果共纳入31项研究。每次胃肠道内镜检查产生约7.8-56.4千克二氧化碳当量,主要受运输、能源使用和一次性用品的影响。在直接的生命周期评估中,CT每个过程的碳足迹为7-10千克二氧化碳当量,而更广泛的机构和模型估计将其扩展到约20千克二氧化碳当量,具体取决于吞吐量、方案和能源。MRI的能量密集程度更高,在大多数研究中,每次扫描的二氧化碳当量为17-22公斤,而在包括全生命周期影响的高场(3T)系统中,每次扫描的二氧化碳当量高达200-300公斤。相比之下,IUS每次扫描仅产生0.5-1.5千克二氧化碳当量,能源需求最小,浪费可以忽略不计。IUS使点护理评估,减少病人的旅行和相关的排放。结论内镜、CT和MRI在IBD的治疗中是必不可少的,但其环境成本较高。IUS的广泛采用提供了一种临床有效的低碳替代方案,可以促进更可持续的IBD管理,与全球健康目标保持一致。普洛斯彼罗国际前瞻性系统评价注册:CRD420251088016
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
BackgroundInflammatory bowel disease (IBD) is a chronic, resource‐intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD—gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)—are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.AimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low‐carbon alternative.MethodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.ResultsThirty‐one studies were included. GI endoscopy generates approximately 7.8–56.4 kg CO2‐equivalent per procedure, largely driven by transportation, energy use and disposables. CT carries a carbon footprint of 7–10 kg CO2e per procedure in direct life cycle assessments, while broader institutional and modelling estimates extend this to ~20 kg CO2e depending on throughput, protocol and energy sources. MRI is substantially more energy‐intensive, ranging from 17–22 kg CO2e per scan in most studies, and up to 200–300 kg CO2e for high‐field (3T) systems when full life cycle impacts are included. In contrast, IUS produces only 0.5–1.5 kg CO2e per scan, with minimal energy demand and negligible waste. IUS enables point‐of‐care assessments, reducing patient travel and associated emissions.ConclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low‐carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.Trial RegistrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信